Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells
Year: 1989
Type: article
Source: Cancer Immunology Immunotherapy
DOI: 10.1007/bf00199117
Authors: A.L. Asher, J.J. Mul�, S.A. Rosenberg
Institutions: National Cancer Institute, National Institutes of Health
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2069322747